Glìalia is a specialized nutritional product categorized as a Food for Special Medical Purposes (FSMP), specifically designed to manage neuroinflammatory processes. It is formulated with a patented combination of Palmitoylethanolamide (PEA) and Luteolin, which work synergistically to support tissue homeostasis in the central nervous system. This product is typically used under medical supervision for patients dealing with cognitive decline, early-stage neurodegenerative diseases, or recovery from stroke and trauma.

The brand is owned and manufactured by EPITECH Group SpA, an Italian pharmacology and biotechnology company headquartered in Milan. EPITECH is recognized for its extensive research into neuroinflammation and its proprietary ultra-micronization technologies, which are used to improve the bioavailability of its active ingredients. The product is primarily produced in Italy, reflecting the company's European manufacturing base and scientific heritage.

Glialia tablets